Guillain-Barré Syndrome Warning Added to AstraZeneca’s Vaxzevria COVID

Guillain-Barré Syndrome Warning Added to AstraZeneca’s Vaxzevria COVID

The European Medicines Agency (EMA) last week added an autoimmune condition known as Guillain-Barré syndrome (GBS) as a possible side effect to the product information on AstraZeneca/Oxford University’s Vaxzevria (or “AZD1222”) experimental adenovirus vectored vaccine. GBS is a neurological disorder that causes pain, numbness, muscle weakness and sometimes paralysis.1 2 3 4 A total of […]

Canada Adds Bell’s Palsy Warning to Pfizer COVID Shot

Canada Adds Bell’s Palsy Warning to Pfizer COVID Shot

Health Canada, the Canadian government’s department responsible for national health policy, earlier this month updated the product information label for Pfizer/BioNTech’s experimental messenger RNA (mRNA) biologic (also known as BNT162b2 or “Comirnaty” vaccine) to reflect reported cases of Bell’s palsy—an immune mediated neurological disorder characterized by temporary muscle weakness or paralysis on one side of […]

Many Americans Worry About the Safety of COVID Biologics

Many Americans Worry About the Safety of COVID Biologics

A new poll conducted Yahoo! News/YouGov during July 13-15, 2021 found that 37 percent of unvaccinated Americans are more fearful of the three experimental COVID-19 biologics currently available in the United States than they are of the SARS-CoV-2 virus that can cause the disease. The survey of 1,715 adults in the U.S. found that only […]

Coronavirus Spreading Among the Vaccinated in Highly Vaccinated Countries

Coronavirus Spreading Among the Vaccinated in Highly Vaccinated Countries

A recent study published by King’s College in London, which operates the ZOE COVID Study app to monitor COVID infection and vaccination rates, found that, as of July 15, 2021, there was an average of 15,537 new daily symptomatic cases of COVID-19 among partly or fully vaccinated people in the United Kingdom—an increase of 40 […]

Journal Article Questioning COVID Vaccination Protocols Retracted

Journal Article Questioning COVID Vaccination Protocols Retracted

A scholarly article published in a medical journal, in which authors concluded that a “lack of clear benefit should cause governments to rethink their vaccination policy,” has been retracted less than two weeks after publication. The article entitled “The Safety of COVID-19 Vaccinations—We Should Rethink the Policy” was published by MDPI (Multidisciplinary Digital Publishing Institute) […]

Italy Suspends AstraZeneca’s COVID Vaccine After Teen’s Brain Hemorrhage Death

Italy Suspends AstraZeneca’s COVID Vaccine After Teen’s Brain Hemorrhage Death

The government of Italy has suspended AstraZeneca/Oxford University’s experimental AZD1222 COVID-19 vaccine for people under 60 years of age in that country. The decision, announced on June 11, 2021, follows the recent death of 18-year-old Camilla Canepa, who died of a cerebral  due to a blood clot 16 days after receiving the first dose of […]

NIH Begins Testing Mixed COVID-19 Vaccine Schedules

NIH Begins Testing Mixed COVID-19 Vaccine Schedules

The U.S. National Institutes of Health (NIH) has announced that it has begun an early stage Phase 1/2 clinical trial to examining what happens when an adult who is fully vaccinated with one type of COVID-19 vaccine, is given a different booster vaccine from another manufacturer three to four months later.1 Currently, there are three […]

Pfizer Poised to Dominate U.S. Market for COVID-19 Biologics

Pfizer Poised to Dominate U.S. Market for COVID-19 Biologics

Last week was a bad one for COVID-19 biologics produced by Moderna, Inc. and Johnson & Johnson, Inc. (J&J). News reports began filtering out about new research from the U.S. Centers for Disease Control and Prevention (CDC), which were published on Apr. 5, 2021 in the journal JAMA and revealed that people who receive Moderna’s […]

Johnson & Johnson’s COVID-19 Vaccine Suspended After Blood Disorder Reports

Johnson & Johnson’s COVID-19 Vaccine  Suspended After Blood Disorder Reports

A manufacturing plant in Baltimore, Maryland where two experimental COVID-19 vaccines are manufactured has caused the U.S. Food and Drug Administration (FDA) to delay authorization of the plant’s production lines due to the contamination of 15 million doses of Johnson & Johnson’s (J&J) COVID-19 vaccine.1 Ingredients Used in Two COVID-19 Vaccines “Mixed Up” During Production […]

1 2 3 4